Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| 1 |
Bank of America
BAC
|
+$392M |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$330M |
| 3 |
Blackrock
BLK
|
+$296M |
| 4 |
SPDR S&P Regional Banking ETF
KRE
|
+$287M |
| 5 |
iShares Gold Trust
IAU
|
+$284M |
Top Sells
| 1 |
NVIDIA
NVDA
|
+$758M |
| 2 |
SPDR S&P 500 ETF Trust
SPY
|
+$675M |
| 3 |
Microsoft
MSFT
|
+$632M |
| 4 |
Tesla
TSLA
|
+$607M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$396M |
Sector Composition
| 1 | Technology | 29.03% |
| 2 | Financials | 11.03% |
| 3 | Consumer Discretionary | 10.8% |
| 4 | Communication Services | 7.24% |
| 5 | Healthcare | 7.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1901
Uranium Energy
UEC
$5.27B
| $2.17M | ﹤0.01% |
319,246
-477
| -0.1% | -$3.24K |
|
1902
Lithia Motors
LAD
$8.56B
| $2.17M | ﹤0.01% |
6,426
-1,611
| -20% | -$544K |
|
1903
Rhythm Pharmaceuticals
RYTM
$6.39B
| $2.17M | ﹤0.01% |
34,324
-51,882
| -60% | -$3.28M |
|
1904
Interparfums
IPAR
$3.43B
| $2.16M | ﹤0.01% |
16,465
-10,166
| -38% | -$1.33M |
|
1905
Dutch Bros
BROS
$8.2B
| $2.16M | ﹤0.01% |
31,599
+3,578
| +13% | +$245K |
|
1906
Core & Main
CNM
$9.28B
| $2.16M | ﹤0.01% |
35,754
-9,671
| -21% | -$584K |
|
1907
Herc Holdings
HRI
$4.2B
| $2.15M | ﹤0.01% |
16,331
-14,524
| -47% | -$1.91M |
|
1908
Virtus Investment Partners
VRTS
$1.34B
| $2.15M | ﹤0.01% |
11,852
+1,886
| +19% | +$342K |
|
1909
Envista
NVST
$3.49B
| $2.15M | ﹤0.01% |
109,987
-24,076
| -18% | -$470K |
|
|
XHR
1910
Xenia Hotels & Resorts
XHR
$1.41B
| $2.14M | ﹤0.01% |
170,172
-20,077
| -11% | -$252K |
|
1911
Soleno Therapeutics
SLNO
$2.85B
| $2.13M | ﹤0.01% |
25,467
-29,651
| -54% | -$2.48M |
|
1912
Veracyte
VCYT
$2.43B
| $2.13M | ﹤0.01% |
78,913
-75,718
| -49% | -$2.05M |
|
1913
Fate Therapeutics
FATE
$111M
| $2.13M | ﹤0.01% |
1,903,738
-33,395
| -2% | -$37.4K |
|
|
SFD
1914
Smithfield Foods, Inc. Common Stock
SFD
$9.6B
| $2.13M | ﹤0.01% |
90,514
+89,544
| +9,231% | +$2.11M |
|
1915
B&G Foods
BGS
$360M
| $2.13M | ﹤0.01% |
502,783
+388,470
| +340% | +$1.64M |
|
1916
Westamerica Bancorp
WABC
$1.24B
| $2.13M | ﹤0.01% |
43,872
-4,897
| -10% | -$237K |
|
1917
89bio
ETNB
$1.2B
| $2.12M | ﹤0.01% |
216,325
+9,195
| +4% | +$90.3K |
|
1918
Ryder
R
$7.65B
| $2.12M | ﹤0.01% |
13,354
+2,556
| +24% | +$406K |
|
1919
Evolent Health
EVH
$1.05B
| $2.12M | ﹤0.01% |
188,229
-331,530
| -64% | -$3.73M |
|
1920
BlackBerry
BB
$2.32B
| $2.12M | ﹤0.01% |
461,672
+85,878
| +23% | +$394K |
|
1921
Fastly
FSLY
$1.14B
| $2.12M | ﹤0.01% |
299,951
-22,850
| -7% | -$161K |
|
1922
S&T Bancorp
STBA
$1.5B
| $2.11M | ﹤0.01% |
55,913
-16,158
| -22% | -$611K |
|
1923
Enerpac Tool Group
EPAC
$2.3B
| $2.11M | ﹤0.01% |
52,107
-29,813
| -36% | -$1.21M |
|
1924
RXO
RXO
$2.71B
| $2.11M | ﹤0.01% |
134,337
-81,496
| -38% | -$1.28M |
|
1925
Goldman Sachs Access Treasury 0-1 Year ETF
GBIL
$6.23B
| $2.11M | ﹤0.01% |
21,077
+1,539
| +8% | +$154K |
|